Publications

5808 Results

Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification Consortium [includes representation by SWOG]

Authors
B Cheson;RI Fisher;SF Barrington;F Cavailli;LH Schwartz;E Zucca;TA Lister
Journal / Conference
Journal of Clinical Oncology Sep 20;32(27):3059-3068
Year
2014
Research Committee(s)
Lymphoma
PMID
PMID25113753
PMC
PMC4979083

Future perspectives in melanoma research: meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013

Authors
PA Ascierto;AM Grimaldi;A Carrizosa Anderson;C Bifulco;A Cochran;C Garbe;AM Eggermont;M Faries;S Ferrone;J Gershenwald;TF Gajewski;R Halaban;FS Hodi;R Kefford;JM Kirkwood;J Larkin;S Leachman;M Maio;R Marais;G Masucci;I Melero;G Palmieri;A Puzanov;A Ribas;Y Saenger;B Schilling;B Seliger;D Stroncek;R Sullivan;A Testori;E Wang;G Ciliberto;N Mozzillo;FM Marincola;M Thurin
Journal / Conference
Journal of Translational Medicine Oct 28;12(1):277
Year
2014
Research Committee(s)
Melanoma
PMID
PMID25348889
PMC
PMC4232645
Study Number(s)
S0008, S1404

Re: Long-term survival of participants in the Prostate Cancer Prevention Trial

Authors
IM Thompson;C Tangen;P Goodman
Journal / Conference
Asian Journal of Andrology May-Jun;16(3):414
Year
2014
Research Committee(s)
Cancer Control
PMID
PMID24914438
PMC
PMC4023368
Study Number(s)
SWOG-9217

Randomized phase II trial of capecitabine and lapatinib with or without cixutumumab in patients with HER2+ breast cancer previously treated with trastuzumab and an anthracycline and/or a taxane: NCCTG N0733 (Alliance)

Authors
P Haluska;AM Bernath;K Ballman;A Dueck;H Linden;M Goetz;MX Hou;L Tenner;P Tienchaiananda;LM Flickinger;B Chen;HX Chen;W Lingle;C Pellegrino;RW Sponzo;M Reinholz;EA Perez
Journal / Conference
Journal of Clinical Oncology 32:5s(suppl; abstr 632); ASCO Annual Meeting (May 30-June 3, 2014, Chicago, IL), general poster session;
Year
2014
Research Committee(s)
Breast

Arsenic trioxide in front-line therapy of acute promyelocytic leukemia (C9710): prognostic significance of FLT3 mutations and complex karyotype

Authors
X Poire;BK Moser;R Gallagher;K Laumann;C Bloomfield;B Powell;G Koval;K Gulati;N Holowka;R Larson;M Tallman;F Appelbaum;D Sher;CL Willman;E Paietta;W Stock
Journal / Conference
Leukemia & Lymphoma 55(7):1523-1532
Year
2014
Research Committee(s)
Leukemia
PMID
PMID24160850
PMC
PMC4273565
Study Number(s)
C9710

Novel neoadjuvant therapy paradigms for bladder cancer: results from the National Cancer Center Institute Forum

Authors
C Dinney;D Hansel;D McConkey;W Shipley;M Hagan;R Dreicer;S Lerner;B Czerniak;F Waldman;S Groshen;LD True;E Petricoin;D Theodorescu;A Hruszkewycz;D Bajorin
Journal / Conference
Urologic Oncology 32(8):1108-15;
Year
2014
Research Committee(s)
Genitourinary
PMID
PMID25443274
PMC
PMC4262150
Study Number(s)
S1314

Study of candidate SNP associations of optimism and resilence in older adults: exploratory study of 935 community-dwelling adults

Authors
B Rana;L Darst;C Bloss;B Shih;C Depp;C Nievergelt;M Allison;JK Parsons;N Schork;DV Jeste
Journal / Conference
American Journal of Geriatric Psychiatry Oct;22(10):997-1006
Year
2014
Research Committee(s)
Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
PMID
PMID24791650
PMC
PMC4163500
Study Number(s)
S0000

Supplement use during an intergroup clinical trial for breast cancer (S0221)

Authors
G Zirpoli;P Brennan;C-C Hong;S McCann;G Ciupak;W Davis;J Unger;G Budd;D Hershman;HCF Moore;J Stewart;C Isaacs;T Hobday;M Salim;G Hortobagyi;J Gralow;K Albain;CB Ambrosone
Journal / Conference
Breast Cancer Research and Treatment 137(3):903-913;
Year
2013
Research Committee(s)
Breast
PMID
PMID23306462
PMC
PMC3552360
Study Number(s)
S0221

SWOG phase II trial (S0526) of pemetrexed in patients with metastatic bronchioloalveolar carinoma (BAC)

Authors
DHM Lau;J Moon;AM Davies;R Sanborn;F Hirsch;W Franklin;J Ruzich;M Redman;DR Gandara
Journal / Conference
Clinical Lung Cancer 14(4):351-355;
Year
2013
Research Committee(s)
Lung
PMID
PMID23415808
PMC
PMC4567037
Study Number(s)
S0526

Phase II trial of cisplatin plus etoposide plus gemcitabine plus solumedrol (PEGS) in peripheral T-cell non-Hodgkin Lymphoma (SWOG S0350)

Authors
D Mahadevan;J Moon;D Persky;F Young;M Leblanc;RI Fisher;TP Miller
Journal / Conference
Cancer 119(2):371-379;
Year
2013
Research Committee(s)
Lymphoma
PMID
PMID22833464
PMC
PMC3485430
Study Number(s)
S0350